XML 46 R31.htm IDEA: XBRL DOCUMENT v3.21.1
SHARE-BASED PAYMENTS (Tables)
3 Months Ended
Mar. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The fair value of the options granted under the Compensation Plan for the three months ended March 31, 2021 was estimated at the date of grant, using the Black-Scholes Option Valuation Model, with the following weighted average assumptions:
Risk-free interest rate0.42 %
Expected life5.0 years
Expected volatility61.88 %*
Expected dividend yield— %
Weighted average grant date fair value$2.03 
* Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the options.
Schedule of Share-based Compensation, Stock Options, Activity The summary of the Company’s stock options at March 31, 2021 and December 31, 2020, and the changes for the fiscal periods ending on those dates, is presented below:
 Range of Exercise PricesWeighted Average
Exercise Price
Number of
Options 
Balance, December 31, 2019
$1.70 - $15.61
$3.43 1,487,433 
 Granted
1.76 - 3.06
1.77 711,414 
 Exercised
 1.70 - 2.92
1.97 (302,707)
 Forfeited
1.70 - 5.18
3.26 (188,541)
 Expired
4.12 - 5.22
4.40 (98,512)
Balance, December 31, 2020
$1.70 - $15.61
$2.91 1,609,087 
 Granted
3.89 - 7.14
3.93 162,920 
 Exercised
1.70 - 4.48
2.40 (278,111)
 Forfeited— — — 
 Expired
2.12 - 15.61
9.65 (22,836)
Balance, March 31, 2021
$1.70 - $12.59
$3.02 1,471,060 
A summary of the status and activity of non-vested stock options for the three months ended March 31, 2021 is as follows:
 Number of SharesWeighted Average Grant Date Fair Value
Non-vested December 31, 2020403,990 $0.94 
 Granted162,920 2.03 
 Vested(280,438)1.35 
 Forfeited— — 
Non-vested March 31, 2021286,472 $1.16 
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
A summary of the status and activity of non-vested RSUs for the three months ended March 31, 2021 is as follows:
 Number of SharesWeighted Average Grant Date Fair Value
Non-vested December 31, 20201,094,056 $1.98 
 Granted441,241 3.89 
 Vested(635,233)1.94 
 Forfeited— — 
Non-vested March 31, 2021900,064 $2.94 
The summary of the Company’s SARs at March 31, 2021 and December 31, 2020, and the changes for the fiscal periods ending on those dates, is presented below:
 Weighted Average
Exercise Price
Number of
SARs
Balance, December 31, 2019$2.92 2,165,509 
 Granted— — 
 Exercised— — 
 Forfeited2.92 (444,886)
 Expired— — 
Balance, December 31, 2020$2.92 1,720,623 
 Granted— — 
 Exercised— — 
 Forfeited— — 
 Expired— — 
Balance, March 31, 2021$2.92 1,720,623 
A summary of the status and activity of non-vested SARs for the three months ended March 31, 2021 is as follows:
 Number of SharesWeighted Average Grant Date Fair Value
Non-vested December 31, 20201,720,623 $1.25 
 Granted— — 
 Vested(573,537)1.25 
 Forfeited— — 
Non-vested March 31, 20211,147,086 $1.25